Roger Lacave

3.0k total citations
73 papers, 1.7k citations indexed

About

Roger Lacave is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Roger Lacave has authored 73 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Roger Lacave's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (10 papers) and Cancer Genomics and Diagnostics (8 papers). Roger Lacave is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (10 papers) and Cancer Genomics and Diagnostics (8 papers). Roger Lacave collaborates with scholars based in France, Switzerland and United Kingdom. Roger Lacave's co-authors include Éric Rondeau, Marcelle Bens, Alain Vandewalle, S Ricci, Françoise Cluzeaud, Martine Antoine, Jean–Daniel Sraer, Jean‐François Bernaudin, F Delarue and Jacques Cadranel and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and JNCI Journal of the National Cancer Institute.

In The Last Decade

Roger Lacave

68 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger Lacave France	26	647	600	594	337	317	73	1.7k
Hannes Neuwirt Austria	23	787 1.2×	548 0.9×	483 0.8×	148 0.4×	418 1.3×	62	1.8k
Hervé Sartelet France	23	807 1.2×	527 0.9×	224 0.4×	139 0.4×	377 1.2×	82	1.7k
Elena De Mattia Italy	25	725 1.1×	963 1.6×	324 0.5×	198 0.6×	279 0.9×	92	2.0k
Ramin Radpour Switzerland	30	1.3k 2.0×	595 1.0×	329 0.6×	152 0.5×	704 2.2×	72	2.7k
Lydia Nakopoulou Greece	27	1.0k 1.6×	863 1.4×	400 0.7×	330 1.0×	684 2.2×	79	2.3k
Stephan Macher‐Goeppinger Germany	28	1.1k 1.7×	436 0.7×	527 0.9×	358 1.1×	448 1.4×	59	2.1k
H Nizze Germany	20	446 0.7×	665 1.1×	214 0.4×	533 1.6×	140 0.4×	71	1.6k
Anthony E. Dear Australia	25	1.0k 1.6×	258 0.4×	629 1.1×	495 1.5×	171 0.5×	51	2.3k
Teruhiko Yoshida Japan	24	1.1k 1.7×	1.1k 1.8×	974 1.6×	269 0.8×	464 1.5×	54	2.2k
Yoriaki Kaneko Japan	26	529 0.8×	290 0.5×	250 0.4×	256 0.8×	112 0.4×	91	2.6k

Countries citing papers authored by Roger Lacave

Since Specialization

Citations

This map shows the geographic impact of Roger Lacave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Lacave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Lacave more than expected).

Fields of papers citing papers by Roger Lacave

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Lacave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Lacave. The network helps show where Roger Lacave may publish in the future.

Co-authorship network of co-authors of Roger Lacave

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Lacave. A scholar is included among the top collaborators of Roger Lacave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Lacave. Roger Lacave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beau‐Faller, Michèle, Erwan Pencreach, Charlotte Leduc, et al.. (2019). Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project. Lung Cancer. 140. 19–26. 13 indexed citations

Duruisseaux, M., Martine Antoine, Nathalie Rabbe, et al.. (2017). Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers. Lung Cancer. 109. 92–100. 27 indexed citations

Leduc, Charlotte, Erwan Pencreach, J.P. Merlio, et al.. (2017). Ultrasensitive detection of EGFR T790M mutation by droplet digital PCR (ddPCR) in TKI naïve non-small cell lung cancer (NSCLC) harboring EGFR mutation: Results of the nationwide program Biomarkers France of the French Cooperative Thoracic Intergroup (IFCT). Annals of Oncology. 28. v22–v23.

Perkins, Géraldine, Elizabeth Fabre, Vincent Fallet, et al.. (2016). Whole exome sequencing (WES) and RNA sequencing (RNA-seq) in routine clinical practice for colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) patients (pts). Annals of Oncology. 27. vi29–vi29.

Duménil, Coraline, Thibault Vieira, Étienne Rouleau, et al.. (2015). Is there a specific phenotype associated with the different subtypes of KRAS mutations in patients with advanced non-small-cell lung cancers?. Lung Cancer. 90(3). 561–567. 7 indexed citations

Vieira, Thibault, Martine Antoine, Anne-Marie Ruppert, et al.. (2014). Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung. Lung Cancer. 85(2). 276–281. 63 indexed citations

Fallet, Vincent, Anne-Marie Ruppert, Virginie Poulot, et al.. (2012). Secondary Resistance to Erlotinib: Acquired T790M Mutation and Small-Cell Lung Cancer Transformation in the Same Patient. Journal of Thoracic Oncology. 7(6). 1061–1063. 16 indexed citations

Antoine, Martine, Virginie Poulot, Magali Colombat, et al.. (2010). Biologie moléculaire préthérapeutique sur prélèvements biopsiques de petite taille. Annales de Pathologie. 30(5). 67–72. 3 indexed citations

Moureau-Zabotto, Laurence, S Ricci, Florence Coulet, et al.. (2006). Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients. British Journal of Cancer. 94(4). 473–480. 35 indexed citations

10.

Pimpec‐Barthes, Françoise Le, Claire Danel, Roger Lacave, et al.. (2004). Association of CK19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence. European Journal of Cancer. 41(2). 306–312. 30 indexed citations

11.

Colombo, B., Roger Lacave, Catherine Pioche‐Durieu, et al.. (2000). Cellular but not humoral immune responses generated by vaccination with dendritic cells protect mice against leukaemia. Immunology. 99(1). 8–15. 6 indexed citations

12.

Peng, Kou‐Cheng, Françoise Cluzeaud, Marcelle Bens, et al.. (1999). Tissue and Cell Distribution of the Multidrug Resistance-Associated Protein (MRP) in Mouse Intestine and Kidney. Journal of Histochemistry & Cytochemistry. 47(6). 757–767. 110 indexed citations

13.

Lacave, Roger, Florence Coulet, S Ricci, et al.. (1998). Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas. British Journal of Cancer. 77(5). 694–702. 22 indexed citations

14.

Urban, T., S Ricci, Roger Lacave, et al.. (1996). Codon 12 Ki-ras mutation in non-small-cell lung cancer: comparative evaluation in tumoural and non-tumoural lung. British Journal of Cancer. 74(7). 1051–1055. 12 indexed citations

15.

Urban, T., S Ricci, Jean Didier Grangè, et al.. (1993). Detection of c-Ki-ras Mutation by PCR/RFLP Analysis and Diagnosis of Pancreatic Adenocarcinomas. JNCI Journal of the National Cancer Institute. 85(24). 2008–2012. 69 indexed citations

16.

Texier, Pascale, Yves de Keyzer, Roger Lacave, et al.. (1991). Proopiomelanocortin Gene Expression in Normal and Tumoral Human Lung*. The Journal of Clinical Endocrinology & Metabolism. 73(2). 414–420. 28 indexed citations

17.

Rondeau, Éric, Bertrand Guidet, Roger Lacave, et al.. (1990). Nordihydroguaiaretic acid inhibits urokinase synthesis by phorbol myristate acetate-stimulated LLC-PK1 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1055(2). 165–172. 13 indexed citations

18.

Bachner, Lucien, Marie‐Claude Vinet, Roger Lacave, et al.. (1990). Linkage study of a large family with autosomal dominant polycystic kidney disease with reduced expression. Human Genetics. 85(2). 221–7. 21 indexed citations

19.

Peraldi, M.N., Éric Rondeau, Roger Lacave, et al.. (1990). Dexamethasone increases preproparathyroid hormone messenger RNA in human hyperplastic parathyroid cells in vitro. European Journal of Clinical Investigation. 20(4). 392–397. 16 indexed citations

20.

Sraer, Jean–Daniel, A Kanfer, Eric Rondeau, & Roger Lacave. (1989). Role of the Renin-Angiotensin System in the Regulation of Glomerular Filtration. Journal of Cardiovascular Pharmacology. 14(4). S21–S25. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact